UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-31 | Future report Set alerts | |
| Q2 2022 | 2022-07-27 | 1.47 | 1.47 |
| Q1 2022 | 2022-04-27 | 1.23 | 1.23 |
| Q4 2021 | 2022-02-23 | 1.18 | 1.18 |
| Q3 2021 | 2021-11-02 | 1.53 | 1.53 |
| Q2 2021 | 2021-08-04 | 1.69 | 1.69 |
| Q1 2021 | 2021-04-28 | 1.54 | 1.54 |
| Q4 2020 | 2021-02-24 | 1.49 | 1.49 |
| Q3 2020 | 2020-10-28 | 0.00 | 0.00 |
| Q2 2020 | 2020-07-28 | 1.34 | 1.04 |
| 2016-06-16 | Initiated Coverage | Stephens | Equal Weight | $55.00 |
| 2016-05-25 | Reiterated Rating | Jefferies Group | Buy | $59.00 |
| 2016-05-16 | Reiterated Rating | Robert W. Baird | Hold | |
| 2016-05-06 | Boost Price Target | RBC Capital | Sector Perform | $41.00 to $48.00 |
| 2016-05-06 | Boost Price Target | Royal Bank Of Canada | Sector Perform | $41.00 to $48.00 |
| 2016-05-04 | Reiterated Rating | Oppenheimer | Buy | $56.00 |
| 2016-05-04 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | $56.00 |
| 2016-04-11 | Reiterated Rating | Mizuho | Buy | $49.00 to $57.00 |
| 2016-03-17 | Reiterated Rating | Oppenheimer | Outperform | $45.00 |
| 2016-03-11 | Reiterated Rating | Mizuho | Buy | $49.00 |
| 2016-03-10 | Reiterated Rating | Jefferies Group | Buy | $48.00 |
| 2016-03-10 | Reiterated Rating | Oppenheimer | Outperform | $40.00 to $45.00 |
| 2016-02-08 | Upgrade | Oppenheimer | Market Perform to Outperform | $40.00 |
| 2016-01-19 | Upgrade | Mizuho | Neutral to Buy | $45.00 to $49.00 |
| 2016-01-13 | Lower Price Target | Robert W. Baird | Neutral | $43.00 to $39.00 |
| 2016-01-11 | Upgrade | Raymond James | Underperform to Market Perform | |
| 2016-01-11 | Upgrade | Raymond James Financial Inc. | Underperform to Market Perform | |
| 2015-11-27 | Boost Price Target | RBC Capital | Sector Perform | $25.00 to $41.00 |
| 2015-11-26 | Upgrade | Robert W. Baird | Underperform to Neutral | $9.00 to $10.00 |
| 2015-11-26 | Lower Price Target | Jefferies Group | Hold | $15.00 to $12.00 |
| 2015-11-11 | Downgrade | Mizuho | Buy to Neutral | $45.00 |
| 2015-11-06 | Reiterated Rating | Piper Jaffray | Neutral | $42.00 to $45.00 |
| 2015-11-06 | Reiterated Rating | Piper Jaffray Cos. | Neutral | $42.00 to $45.00 |
| 2015-10-06 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2015-09-01 | Initiated Coverage | Wells Fargo & Co. | Outperform | |
| 2015-09-01 | Initiated Coverage | Wells Fargo | Outperform | |
| 2015-07-16 | Reiterated Rating | Piper Jaffray | Hold | $30.00 to $41.00 |
| 2015-06-30 | Initiated Coverage | Mizuho | Buy | $45.00 |
| 2015-06-19 | Upgrade | Jefferies Group | Hold to Buy | $30.00 to $48.00 |
| 2015-06-09 | Upgrade | Deutsche Bank | Hold to Buy | $28.00 to $41.00 |
| 2015-06-09 | Reiterated Rating | Jefferies Group | Hold | |
| 2015-06-09 | Upgrade | Deutsche Bank AG | Hold to Buy | $28.00 to $41.00 |
| 2015-05-27 | Upgrade | SunTrust | Neutral to Buy | $31.00 to $36.00 |
| 2015-05-27 | Upgrade | SunTrust Banks Inc. | Neutral to Buy | $31.00 to $36.00 |
| 2015-05-24 | Reiterated Rating | Deutsche Bank | Hold | $28.00 |
| 2015-05-07 | Reiterated Rating | RBC Capital | Sector Perform | $23.00 to $25.00 |
| 2015-04-30 | Boost Price Target | Deutsche Bank | Hold | $27.00 to $28.00 |
| 2015-03-05 | Reiterated Rating | Oppenheimer | Hold | |
| 2015-03-05 | Boost Price Target | Jefferies Group | Hold | $25.00 to $30.00 |
| 2015-03-05 | Reiterated Rating | Piper Jaffray | Neutral | $24.00 to $28.00 |
| 2014-12-01 | Upgrade | RBC Capital | Underperform to Sector Perform | $10.00 to $23.00 |
| 2014-10-30 | Reiterated Rating | Jefferies Group | Hold | $16.50 to $25.00 |
| 2014-10-30 | Reiterated Rating | Credit Suisse | Underperform | $17.00 to $23.00 |
| 2014-10-30 | Reiterated Rating | Credit Suisse Group AG | Underperform | $17.00 to $23.00 |
| 2014-10-29 | Upgrade | Robert W. Baird | Underperform to Neutral | $15.00 to $25.00 |
| 2014-07-31 | Reiterated Rating | SunTrust | Neutral | $18.00 to $23.00 |
| 2014-07-31 | Reiterated Rating | Credit Suisse | Underperform | $9.00 to $17.00 |
| 2014-07-31 | Reiterated Rating | Deutsche Bank | Hold | $14.00 to $22.00 |
| 2014-07-31 | Boost Price Target | Piper Jaffray | Neutral | $12.00 to $18.00 |
| 2014-07-31 | Boost Price Target | Jefferies Group | Hold | $12.00 to $16.50 |
| 2014-07-18 | Boost Price Target | RBC Capital | Underperform | $7.00 to $10.00 |
| 2014-06-30 | Upgrade | Deutsche Bank | Sell to Hold | $8.00 to $14.00 |
| 2014-06-27 | Upgrade | CRT Capital | Sell to Fair Value | |
| 2014-06-02 | Downgrade | Avondale Partners | Outperform to Market Perform | |
| 2014-05-12 | Lower Price Target | Piper Jaffray | $13.00 to $12.00 | |
| 2014-03-13 | Lower Price Target | Credit Suisse | $10.00 to $9.00 | |
| 2014-03-11 | Downgrade | Oppenheimer | Outperform to Market Perform | $16.00 |
| 2013-11-25 | Upgrade | Avondale Partners | Market Perform to Outperform | |
| 2013-11-13 | Downgrade | Deutsche Bank | Hold to Sell | $11.00 to $8.00 |
| 2013-11-12 | Downgrade | CRT Capital | Fair Value to Sell | |
| 2013-10-28 | Reiterated Rating | Credit Suisse | Underperform | $10.00 to $16.91 |
| 2013-10-21 | Downgrade | RBC Capital | Sector Perform to Underperform | $10.00 to $9.00 |
| 2013-08-09 | Upgrade | CRT Capital | Sell to Fair Value | |
| 2013-06-28 | Reiterated | CRT Capital | Sell | $3 |
| 2013-03-13 | Reiterated | Argus | Hold | $12 to $11 |
| 2012-05-15 | Upgrade | Robert W. Baird | Underperform to Neutral | $9 to $10 |
| 2012-03-08 | Reiterated | RBC Capital Mkts | Sector Perform | $11 to $13 |
| 2012-01-10 | Downgrade | Robert W. Baird | Neutral to Underperform | $10 to $8 |
| 2011-10-27 | Downgrade | BB&T Capital Mkts | Hold to Underweight | |
| 2011-02-23 | Reiterated | RBC Capital Mkts | Sector Perform | $29 to $38 |
| 2011-02-23 | Reiterated | Oppenheimer | Outperform | $38 to $44 |
| 2011-02-23 | Reiterated | FBR Capital | Mkt Perform | $31 to $35 |
| 2011-01-27 | Upgrade | Jefferies | Hold to Buy | $31 to $45 |
| 2011-01-18 | Reiterated | FBR Capital | Mkt Perform | $27 to $31 |
| 2010-12-21 | Upgrade | Deutsche Bank | Hold to Buy | $31 to $39 |
| 2010-10-27 | Reiterated | FBR Capital | Mkt Perform | $29 to $27 |
| 2016-06-16 | Initiated Coverage | Stephens | Equal Weight | $55.00 |
| 2016-05-25 | Reiterated Rating | Jefferies Group | Buy | $59.00 |
| 2016-05-16 | Reiterated Rating | Robert W. Baird | Hold | |
| 2016-05-06 | Boost Price Target | RBC Capital | Sector Perform | $41.00 to $48.00 |
| 2016-05-06 | Boost Price Target | Royal Bank Of Canada | Sector Perform | $41.00 to $48.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AMED 224 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 3.96M |
| Vanguard Group, Inc | 3.04M |
| WELLINGTON MANAGEMENT CO LLP | 2.61M |
| BlackRock Fund Advisors | 2.33M |
| JPMORGAN CHASE & CO | 1.70M |
| RIVERBRIDGE PARTNERS LLC | 1.63M |
| BLACKROCK ADVISORS LLC | 1.30M |
| AMERIPRISE FINANCIAL INC | 1.08M |
| Point72 Asset Management, L.P. | 1.07M |
| MACKENZIE FINANCIAL CORP | 1.00M |
| STATE STREET CORP | 0.87M |
| RS INVESTMENT MANAGEMENT CO LLC | 0.80M |
| BlackRock Group LTD | 0.75M |
| BlackRock Institutional Trust Company, N.A. | 0.71M |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 0.66M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| NORTH TIDE CAPITAL, LLC | 9.97% (3313300) | AFAM / AMED / ELOS / HWAY / SEM / VVUS / |
| BORNE WILLIAM F Chief Executive Officer | 1.33% (440427) | AMED / |
| LABORDE RONALD A | 0.59% (196738) | AMED / |
| Kusserow Paul B. K. CEO and President | 0.27% (90008) | AMED / CNXR / HUM / |
| PITTS DAVID R | 0.26% (88021) | AMED / |
| NETTERVILLE JACK L | 0.24% (79893) | AMED / |
| RICCHIUTI PETER | 0.23% (76600) | AMED / |
| WASHBURN DONALD A | 0.22% (71791) | AMED / GBX / KTEC / LHO / |
| BARFIELD T A JR Chief Development Officer | 0.14% (45353) | AMED / |
| KKR Asset Management LLC | 0.13% (42053) | AMED / KKR / |
| Snow Michael D Chief Operating Officer | 0.12% (40892) | AMED / TMH / |
| JETER JEFFREY D Chief Compliance Officer | 0.11% (36770) | AMED / |
| REDMAN DALE E Chief Financial Officer | 0.09% (30843) | AMED / |
| Bucey David R General Counsel and Secretary | 0.07% (24484) | AMED / |
| Hall Linda J. | 0.07% (24402) | AMED / IRET / |
| North Michael Paul Chief Information Officer | 0.07% (22731) | AMED / |
| McCoy Daniel P Chief Operating Officer | 0.07% (21988) | AMED / |
| Ginn Scott G Principal Accounting Officer | 0.07% (21694) | AMED / |
| Gerard Christopher Chief Operating Officer | 0.06% (21537) | AMED / |
| Kemmerly David L See Remarks | 0.06% (20879) | AMED / |
| Fleming Michael O. Chief Medical Officer | 0.06% (19952) | AMED / |
| Seim Stephen Chief Strategy Officer | 0.06% (19355) | AMED / |
| Pernosky Lawrence R Chief Human Resources Officer | 0.06% (19069) | AMED / |
| WILLIS GARY D Chief Financial Officer | 0.06% (18878) | AMED / |
| PERKINS BRUCE D | 0.05% (17725) | AMED / HUM / |
| Zilkha Nathaniel M | 0.05% (16490) | AMED / |
| Pearce David B. Chief Compliance Officer | 0.05% (16190) | AMED / |
| Howard Martin B Chief Information Officer | 0.05% (15485) | AMED / |
| Sender Susan Chief Clinical Officer | 0.05% (15026) | AMED / |
| Klapstein Julie D | 0.02% (5333) | AMED / QSII / SR / |
| LECHLEITER RICHARD A | 0.02% (5333) | AMED / KND / SYBT / |
| Rideout Jeffrey A | 0.02% (5333) | AMED / |
UM